Big versus small: The impact of aggregate size in disease
Open Access
- 16 June 2023
- journal article
- research article
- Published by Wiley in Protein Science
- Vol. 32 (7) , e4686
Abstract
Protein aggregation results in an array of different size soluble oligomers and larger insoluble fibrils. Insoluble fibrils were originally thought to cause neuronal cell deaths in neurodegenerative diseases due to their prevalence in tissue samples and disease models. Despite recent studies demonstrating the toxicity associated with soluble oligomers, many therapeutic strategies still focus on fibrils or consider all types of aggregates as one group. Oligomers and fibrils require different modeling and therapeutic strategies, targeting the toxic species is crucial for successful study and therapeutic development. Here, we review the role of different‐size aggregates in disease, and how factors contributing to aggregation (mutations, metals, post‐translational modifications, and lipid interactions) may promote oligomers opposed to fibrils. We review two different computational modeling strategies (molecular dynamics and kinetic modeling) and how they are used to model both oligomers and fibrils. Finally, we outline the current therapeutic strategies targeting aggregating proteins and their strengths and weaknesses for targeting oligomers versus fibrils. Altogether, we aim to highlight the importance of distinguishing the difference between oligomers and fibrils and determining which species is toxic when modeling and creating therapeutics for protein aggregation in disease.Keywords
Funding Information
- National Institutes of Health (R35 GM134864, 1RF1 AG071675‐01, 1R01 AT012053)
- National Science Foundation (2210963)
This publication has 317 references indexed in Scilit:
- Mutant SOD1 forms ion channel: Implications for ALS pathophysiologyNeurobiology of Disease, 2012
- Glutathionylation at Cys-111 Induces Dissociation of Wild Type and FALS Mutant SOD1 DimersBiochemistry, 2011
- Effects of Curvature and Composition on α-Synuclein Binding to Lipid VesiclesBiophysical Journal, 2010
- Membrane rafts in Alzheimer's disease beta-amyloid productionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Converse modulation of toxic α-synuclein oligomers in living cells by N′-benzylidene-benzohydrazide derivates and ferric ironBiochemical and Biophysical Research Communications, 2010
- Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosisDiabetologia, 2009
- Ab Initio Folding of Proteins with All-Atom Discrete Molecular DynamicsStructure, 2008
- Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisAnnals of Neurology, 2008
- Intrinsically Disordered Proteins in Human Diseases: Introducing the D2ConceptAnnual Review of Biophysics, 2008
- Mdm2 promotes the rapid degradation of p53Nature, 1997